Monday, January 17, 2022

Zydus Cadila

Registration for teens’ vaccination to begin on CoWIN App from Jan 1

New Delhi: Registration process for adolescents' vaccination on Cowin App will begin from January 1, Cowin Platform Chief Dr RS Sharma said on Monday....

Covid vaccine exclusively for adolescents likely

MoHFW may approve Covid vaccine this month for those aged between 12 years and 18 years

Editorial: Boost to vaccination drive

Nod for Zydus Cadila'd Covid vaccine for children will help India ramp up its vaccination programme quickly

Zydus Cadila gets USFDA nod to market HIV infection treatment tablets

The drug will be manufactured at the group's formulation manufacturing facility at SEZ, Ahmedabad.

Zydus Cadila launches breast cancer treatment drug Ujvira

Zydus Cadila said HER2 positive breast cancer is considered an aggressive form and constitutes 20 to 25 per cent of all breast cancers.

Exploring all options to procure enough vaccines: KTR

Task Force also discussed with them various alternatives to drugs that are in high demand like Remdesivir

Zydus Cadila gets DCGI nod to use hepatitis drug for Covid treatment

Zydus has received restricted emergency use approval from DCGI for the use of 'Virafin', PegIFN in treating moderate COVID-19 infection in adults

Zydus’ Virafin gets emergency use approval for treating moderate COVID-19 cases

This government's approval for use of the antiviral drug comes at a time when India's daily COVID tally is crossing the 3-lakh mark.

Zydus Cadila seeks DCGI nod for use of hepatitis drug for Covid treatment

Phase-III clinical trials with Pegylated Interferon Alpha 2b, which the company sells under the brand name 'PegiHep' have shown promising results in treating COVID-19, Zydus Cadila said

Zydus Cadila gets USFDA nod to market Liothyronine Sodium tablets

New Delhi: Drug firm Zydus Cadila has received final approval from the US health regulator to market Liothyronine Sodium tablets that are used to...

Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccine

The Nation's first indigenously developed DNA vaccine candidate against COVID-19, ZyCoV-D, by M/s Zydus Cadila has been approved by Drugs Controller General of India (DCGI), for the conduct of the Phase III clinical trials

Vaccination for COVID-19 will be voluntary: Health ministry

It also said that protective level of antibodies generally develop two weeks after receiving the second dose.

Zydus Cadila gets DGCI nod for phase 3 clinical trials with biological therapy

The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India.

Gujarat: PM Modi reviews vaccine development at Zydus Cadila facility

Zydus Cadila has announced that the phase-I clinical trial of its vaccine candidate ZyCoV-D is over and it has commenced phase-II clinical trials from August.

Maharashtra CM, Governor not to accompany PM during his SII visit in Pune

Modi began his three-city visit on Saturday to review coronavirus vaccine development work by going to pharma major Zydus Cadila's manufacturing facility near Ahmedabad in the morning.

Latest News

- Advertisement -